Glaucoma Therapeutics Devices Market to grow at a CAGR of 5.8 percent during the forecast period

The Global Glaucoma Therapeutics Devices Market is projected to grow at a CAGR of 5.8% during the forecast period, from 2022 to 2029, to reach a market size of USD 11.24 billion by 2029, up from USD 6.92 billion in 2022.

(EMAILWIRE.COM, September 05, 2023 ) The “Glaucoma Therapeutics Devices Market” was valued USD 6.92 Bn in 2022 and is expected to grow at a CAGR of 5.8 percent over the forecast period to reach USD 11.24 Bn by 2029.

Glaucoma Therapeutics Devices Market Scope and Research Methodology

SWOT and PESTLE analysis were used for the research on the Glaucoma Therapeutics Devices Market that combines quantitative and qualitative methods of research. The search methods help understand the factors influencing the Glaucoma Therapeutics Devices Market growth.

Get a Free Sample Report :https://www.maximizemarketresearch.com/request-sample/209358

Glaucoma Therapeutics Devices Market Dynamics

Increasing incidence of influenza worldwide with the need for medical devices to diagnose and treat the disease is expected to boost the Glaucoma Therapeutics Devices market growth. High cost of Glaucoma Therapeutics Devices is significant restraint for the market growth.

Glaucoma Therapeutics Devices Market Regional Insight

Asia Pacific region is expected to boost the Glaucoma Therapeutics Devices market growth over the forecast period. Increasing number of glaucoma cases have become more prevalent is contribute for the growth of market.

Get a Free Sample Report :https://www.maximizemarketresearch.com/request-sample/209358

Glaucoma Therapeutics Devices Market Segmentation

By Disease indication:

Open angle glaucoma
Angle closure glaucoma
Other glaucomas

By Product type:

Surgical devices
Non-surgical devices

By End-User:

Hospitals
Ophthalmic clinics
Ambulatory surgery centers

By Drug Class:

Beta Blockers
Prostaglandins Analogs
Alpha Adrenergic Agonists
Combination Drugs

Get a Free Sample Report :https://www.maximizemarketresearch.com/request-sample/209358

Glaucoma Therapeutics Devices Key Players Include

Alcon (Novartis AG)
Carl Zeiss Meditec AG
Johnson & Johnson Vision
Bausch + Lomb (Bausch Health Companies Inc.)
Glaukos Corporation
Topcon Corporation
STAAR Surgical Company
NIDEK CO., LTD.
Lumenis Ltd.
Ophthalmic Instrument Company
OCULUS Optikgeräte GmbH
New World Medical, Inc.
Ellex Medical Lasers Limited
Iridex Corporation
Allergan (Abbvie Inc.)
AqueSys, Inc.

Maximize Market Research is leading Information Healthcare research firm, has also published the following reports:

Diabetes Devices Market: The market size is expected to reach USD 30.34 Bn by 2029 at a CAGR of 6.2 percent during the forecast period.

General Surgery Devices Market: The total market size is expected to reach USD 29.96 Bn by 2029 at a CAGR of 8.29 percent over the forecast period.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Read other news from MAXIMIZE MARKET RESEARCH PVT. LTD.

Retail Cash Management Market to Reach USD 9.5 Bn by 2029 at a CAGR 14.6 percent

Retail Cash Management Market size was valued at USD 3.6Bn. in 2022 and the total Retail Cash Management Market revenue is expected to grow by 14.6 % from 2023 to 2029, reaching nearly USD 9.5 ...Read more

Gaming Software Market expected to reach USD 230.92 Billion by 2029 at a CAGR of 6.8 percent

Global Gaming Software Market size was valued at USD 145.7 Bn in 2022 and is expected to reach USD 230.92 Bn by 2029, at a CAGR of 6.8%. ...Read more

Semiconductor Components Market expected to Reach USD 1331.35 Billion by 2029 at a CAGR of 12.28 percent

Global Semiconductor Components Market size was valued at USD 591.8 Bn in 2022 and is expected to reach USD 1331.35 Bn by 2029, at a CAGR of 12.28% over the forecast period. ...Read more